Primary Site >> Pancreatic Cancer
Gene >> TOP2A
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. PMID: 13679454 |
Ref: A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment. PMID: 15762277 Ref: Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma. PMID: 16170025 |
Ref: [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas]. PMID: 17493384 Ref: Gene expression analysis for predicting gemcitabine sensitivity in pancreatic cancer patients. PMID: 18333132 |
Ref: Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review. PMID: 26380056 |
Ref: Use of molecular studies for treatment of metastatic pleomorphic large cell pancreatic cancers-a novel strategy. PMID: 27034802 |
Ref: The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways. PMID: 28052097 Ref: Nanoparticle-based hyperthermia distinctly impacts production of ROS, expression of Ki-67, TOP2A, and TPX2, and induction of apoptosis in pancreatic cancer. PMID: 28223795 Ref: Integrated clinicopathological features and gene microarray analysis of pancreatic neuroendocrine tumors. PMID: 28479381 Ref: Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients. PMID: 28728050 |
Ref: TOP2A induces malignant character of pancreatic cancer through activating beta-catenin signaling pathway. PMID: 29045811 Ref: The growth inhibitory effect of gambogic acid on pancreatic cancer cells. PMID: 29546614 |